These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26646663)

  • 1. Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.
    Gödeke J; Luxenburger E; Trippel F; Becker K; Häberle B; Müller-Höcker J; von Schweinitz D; Kappler R
    Hepatol Int; 2016 Mar; 10(2):370-6. PubMed ID: 26646663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatoblastomas exhibit marked
    Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
    Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
    Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
    Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.
    Honda S; Miyagi H; Suzuki H; Minato M; Haruta M; Kaneko Y; Hatanaka KC; Hiyama E; Kamijo T; Okada T; Taketomi A
    Pediatr Surg Int; 2013 Nov; 29(11):1147-52. PubMed ID: 23989600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
    Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
    Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
    Li B; Shao Q; Ji D; Li F; Guo X; Chen G
    Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
    Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
    Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and prognostic significance of NDRG2 downregulation in oral squamous cell carcinoma.
    Ahn CH; Kim JH; Shim HW; Shin WJ; Cho YA; Yoon HJ
    Oral Dis; 2024 Oct; 30(7):4287-4302. PubMed ID: 38887830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.
    Wu S; Zhang J; Chen S; Zhou X; Liu Y; Hua H; Qi X; Mao Y; Young KH; Lu T
    Ann Hematol; 2024 Aug; 103(8):2877-2892. PubMed ID: 38842567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MT1G hypermethylation: a potential prognostic marker for hepatoblastoma.
    Sakamoto LH; DE Camargo B; Cajaiba M; Soares FA; Vettore AL
    Pediatr Res; 2010 Apr; 67(4):387-93. PubMed ID: 20032811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
    Feng L; Xie Y; Zhang H; Wu Y
    Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma.
    Sugawara W; Haruta M; Sasaki F; Watanabe N; Tsunematsu Y; Kikuta A; Kaneko Y
    Pediatr Blood Cancer; 2007 Sep; 49(3):240-9. PubMed ID: 16937357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
    Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
    Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of the N-Myc Downstream-Regulated Gene 2 Promoter in Peripheral Blood Mononuclear Cells is Associated with Liver Fibrosis in Chronic Hepatitis B.
    Liu XY; Fan YC; Gao S; Zhao J; Li F; Zhang J; Wang K
    Tohoku J Exp Med; 2017 Feb; 241(2):155-163. PubMed ID: 28202850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma.
    Ling ZQ; Ge MH; Lu XX; Han J; Wu YC; Liu X; Zhu X; Hong LL
    Oncotarget; 2015 Apr; 6(10):8210-25. PubMed ID: 25823664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation of NDRG2 in gastric cancer and its clinical significance.
    Chang X; Li Z; Ma J; Deng P; Zhang S; Zhi Y; Chen J; Dai D
    Dig Dis Sci; 2013 Mar; 58(3):715-23. PubMed ID: 23010743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.
    Honda S; Haruta M; Sugawara W; Sasaki F; Ohira M; Matsunaga T; Yamaoka H; Horie H; Ohnuma N; Nakagawara A; Hiyama E; Todo S; Kaneko Y
    Int J Cancer; 2008 Sep; 123(5):1117-25. PubMed ID: 18537155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.